2014
DOI: 10.1016/j.lungcan.2014.09.006
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic evaluations of small size lung cancers by 18F-FDG PET/CT and thin-section CT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
25
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 25 publications
(28 citation statements)
references
References 19 publications
3
25
0
Order By: Relevance
“…Non-solid tumours usually represent well-differentiated adenocarcinomas. 3 Second, we used a fixed iodinated contrast agent volume rather than a patient body weight-determined contrast agent volume in this study, while contrast media of three iodine concentrations (300, 320 and 370 mgI) were assigned by body weight. This can result in lower enhancement in patients with heavier weight $60 kg.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Non-solid tumours usually represent well-differentiated adenocarcinomas. 3 Second, we used a fixed iodinated contrast agent volume rather than a patient body weight-determined contrast agent volume in this study, while contrast media of three iodine concentrations (300, 320 and 370 mgI) were assigned by body weight. This can result in lower enhancement in patients with heavier weight $60 kg.…”
Section: Discussionmentioning
confidence: 99%
“…For pre-operative evaluation, 18 F-fludeoxyglucose (FDG) positron emission tomography/ CT (PET/CT) associated with tumour glucose metabolism has been widely used to determine invasiveness and to make prognostic predictions in patients with lung cancer. [3][4][5][6] Contrast-enhanced CT has also been used for functional imaging to evaluate intratumoral necrosis, vascularity and fibrosis, which are associated with invasiveness and prognosis. [7][8][9][10][11][12] In the past, both non-contrast and contrast CT were required to quantify contrast enhancement of a tumour.…”
Section: Introductionmentioning
confidence: 99%
“…Given the difference in treatment strategies, accurate staging of SCLC is crucial. However, data concerning the use of 18 F-FDG PET/CT for SCLC staging [25,28,29,[82][83][84][85][86][87], radiotherapy planning [82,83], therapy response evaluation [88][89][90], and prognosis [89][90][91][92][93][94] are limited.…”
Section: Sclcmentioning
confidence: 99%
“…In the study by Tsurugai et al, metabolic values like SUVmax on FDG‐PET/CT was a significant imaging biomarker that was relevant to the prognosis of patients with lung cancers of 3 cm in diameter. Multivariate regression analysis demonstrated that SUVmax was superior to the C / T ratio for predicting postoperative recurrence, particularly for solid type lung cancer . In an another study with early stage NSCLC treated with stereotactic body radiation, while DFS was significantly related with C / T ratio, OS did not show any difference according to 0.50 cut‐off value of C / T ratio in multivariate analyses .…”
Section: Discussionmentioning
confidence: 92%